Skip to main content

Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it

Full Schedule (Non-Certified Courses)

Full Schedule (Non-Certified Courses)

  • Tuesday, September 3, 2024
  • 8:30 AM – 9:30 AM PST
    From Evidence to Practice: New Results from a 1-Year Real-World Study Supporting Use of Topical Capsaicin for Painful Diabetic Peripheral Neuropathy of the Feet
  • 12:00 PM – 1:00 PM PST
    NAVIGATING MIGRAINE TREATMENT: Patient-Focused Strategies for Primary Care
  • 3:00 PM – 4:20 PM PST
    VA/Government Services Reception
  • Wednesday, September 4, 2024
  • 8:30 AM – 9:30 AM PST
    Responsible Pain Management With Opioid Therapy for Patients With Severe and Persistent Pain
  • 12:00 PM – 1:00 PM PST
    Anatomy of Pain: A Guide to Pain Signaling Pathways
  • 12:00 PM – 1:00 PM PST
    What to Do When Pain Relief With Gabapentinoids Isn’t Enough?
  • 5:00 PM – 5:30 PM PST
    Expert Opinion Live - Revisiting Individualized Assessment and Management of OA in the Post COVID-19 Era
  • Thursday, September 5, 2024
  • 8:30 AM – 9:30 AM PST
    Maximizing Time With Patients: An Interactive Discussion Between Patient and Provider About Opioid-Induced Constipation (OIC)
  • 12:00 PM – 1:00 PM PST
    Break the Mold in Pain Biology: The Promise of a New Mechanism That May Overcome the Shortfalls of Current Moderate to Severe Pain Medications
  • 3:00 PM – 3:30 PM PST
    Expert Opinion Live - Say No To Drugs: Neuromodulation Modalities for Migraine and Pain Management
  • 3:30 PM – 4:20 PM PST
    Identifying and Treating Patients With Unresolved Painful Diabetic Peripheral Neuropathy
  • 5:35 PM – 5:45 PM PST
    (Scientific Abstract Poster Live Presentation) Real-world Treatment Outcomes and Patterns of Rimegepant for the Treatment of Migraine in the Guangdong-Hong Kong-Macao Greater Bay Area of China: Interim Results
  • 5:50 PM – 6:00 PM PST
    (Scientific Abstract Poster Live Presentation) Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis
  • 6:05 PM – 6:15 PM PST
    (Scientific Abstract Poster Live Presentation) Decreased Cost Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis
  • 6:20 PM – 6:30 PM PST
    (Scientific Abstract Poster Live Presentation) Investigating Thermal Skin Response to Menthol Containing Topical Products
  • 6:35 PM – 6:45 PM PST
    (Scientific Abstract Poster Live Presentation) Efficacy and Safety of Meloxicam Co-Crystal and a Rapid-Absorption Formulation of Meloxicam in The Treatment of Post-Surgical Dental Pain
  • Friday, September 6, 2024
  • 10:35 AM – 10:45 AM PST
    (Scientific Abstract Poster Live Presentation) Cebranopadol effects on ventilatory drive, central nervous system, and pain